You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

ATOVAQUONE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Atovaquone patents expire, and what generic alternatives are available?

Atovaquone is a drug marketed by Abhai Llc, Abon Pharms Llc, Amneal Pharms, Apotex, Bionpharma, Chartwell Rx, Glenmark Pharms, Hetero Labs Ltd Iii, Lupin Ltd, Glenmark Generics, and Mylan. and is included in eleven NDAs.

The generic ingredient in ATOVAQUONE is atovaquone; proguanil hydrochloride. There are sixteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the atovaquone; proguanil hydrochloride profile page.

Drug patent expirations by year for ATOVAQUONE
Drug Prices for ATOVAQUONE

See drug prices for ATOVAQUONE

Recent Clinical Trials for ATOVAQUONE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Australian Defence Force Malaria and Infectious Disease Institute (ADF MIDI)Phase 4
Naval Medical Research Unit TWO (NAMRU-2)Phase 4
Naval Medical Research CenterPhase 4

See all ATOVAQUONE clinical trials

Pharmacology for ATOVAQUONE
Medical Subject Heading (MeSH) Categories for ATOVAQUONE
Paragraph IV (Patent) Challenges for ATOVAQUONE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
MEPRON Oral Suspension atovaquone 750 mg/5 mL 020500 1 2009-10-20

US Patents and Regulatory Information for ATOVAQUONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abhai Llc ATOVAQUONE atovaquone SUSPENSION;ORAL 210510-001 May 31, 2019 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Glenmark Pharms ATOVAQUONE atovaquone SUSPENSION;ORAL 209685-001 Nov 21, 2018 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Apotex ATOVAQUONE atovaquone SUSPENSION;ORAL 209750-001 Oct 11, 2017 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Mylan ATOVAQUONE AND PROGUANIL HYDROCHLORIDE atovaquone; proguanil hydrochloride TABLET;ORAL 202362-001 May 27, 2014 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.